The association between TP53 mutation types and outcome presented here is also in agreement with the largest study on the TP53 mutation types and association with clinical phenotypes carried out in 630 patients screened for mutations in breast cancer and published by Alsner and co-workers (2008) [37]. Here, TP53 is linked to breast carcinoma.